HKEX: 0867 - China Medical System Holdings Limited

Yield per half year: +11.84%
Sector: Healthcare

China Medical System Holdings Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.63 35.42 -64.33% 10.61 +19.02%
P/S 3.78 7.59 -50.12%
P/BV 1.95 3.68 -47.09%
P/FCF 12.39 55.3 -77.59%
Ev/Ebitda 5.61 2.91 92.92%
Ev/S 2.83 23.72 -88.07%
Ev/FCF 10.38 63.78 -83.72%
E/P 0.0887 0.0326 171.83%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
44.14 -11.9 -470.88% 42.59 +3.64%
ROE 15.95 5.19 207.49%
ROA 13.53 3.47 290.03%
ROIC 0 0 0%
ROS 29.96 -11.49 -360.82%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.448 0.7755 -42.23% 0.4506 -0.5655%
Nеt Debt/Ebitda 0 0.0127 -100%
Debt/Ratio 0.1021 0.1229 -16.91%
Debt/Equity 1.02 0.776 30.98%
Debt/Net Income 0.7539 1.76 -57.11%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
9.47 5.7 66.15% 5.83 +62.48%
Number of years of dividend growth 0 1.13 -100%
DSI 0.8571 0.5838 46.82%
Average dividend growth -3.95 3.2 -223.4%
Average percentage for 5 years 5.83 4.95 17.69%
Average percentage for payments 37.76 23.96 57.6%
Difference from average difference in sector 3.77

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
31.94 28.69 11.33%
Growth impulse Ebitda in 5 years 35.77 -40.52 -188.28%
Growth impulse Net Income in 5 years 22.45 94.84 -76.33%
Growth impulse FCF in 5 years -1.28 91.41 -101.4%
Growth impulse EPS in 5 years 11.08 -118.14 -109.38%
IP Score
6.3/10

Similar companies

WuXi Biologics (Cayman) Inc.

Hangzhou Tigermed Consulting Co., Ltd

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription